Dog Food Deception: Unraveling the DCM Controversy

In recent years, a significant controversy has emerged around dilated cardiomyopathy (DCM) in dogs and its purported link to grain-free pet foods. This issue gained widespread attention in the summer of 2018 when the FDA's Center for Veterinary Medicine unexpectedly announced an investigation into whether grain-free pet foods were causing dogs to develop DCM. This investigation sparked debates and concerns among pet owners, veterinarians, and pet food companies.

At the heart of this controversy are two main points: the idea that carbohydrates are harmful to dogs and the allegation that the veterinary community has been systematically misled by major pet food companies. One prominent company implicated in this controversy is Hills, which, along with its co-conspirators, is accused of manufacturing the DCM controversy to encourage dog owners to switch from boutique brands to Hills products.

Before this controversy, Hills was experiencing stagnant revenue growth. From 2013 to 2018, the company's revenues grew by only 1%, despite the overall U.S. pet food market expanding by more than 30%. This stagnation indicated that Hills was losing market share, even though it had long been the top brand recommended by veterinarians. The investigation into grain-free pet foods and DCM seemed to provide a turning point for the company. In the five years following the FDA's announcement, Hills' revenues nearly doubled, marking a stark turnaround from its previously flat growth.

The strategy Hills employed to regain market share involved leveraging its influence within the veterinary community. This approach is reminiscent of pharmaceutical companies marketing their products through doctors and dentists. By getting veterinarians to recommend their products, even amid controversy, Hills managed to boost its sales significantly. This tactic of influencing trusted professionals to promote products, regardless of the underlying scientific validity, has proven highly effective.

One tool used to uncover the details of this controversy was the Freedom of Information Act (FOIA). This federal law allows citizens to request government records, which can shed light on the actions and decisions of public agencies. By filing a FOIA request with the FDA, researchers were able to obtain crucial information about the DCM investigation, revealing insights into the motivations and actions of the involved parties.

This controversy highlights the broader issue of how marketing and misinformation can shape consumer behavior. Just as pharmaceutical companies use targeted advertising to influence public perception, pet food companies can manipulate market dynamics through strategic communication. This case underscores the importance of critical thinking and the need for consumers to seek sound, evidence-based information when making decisions about their pets' health and nutrition.

Curious about the real story behind the DCM controversy and how pet food companies influence what vets recommend? Tune in to "THE RAW DOG FOOD TRUTH PODCAST" to uncover eye-opening insights, detailed investigations, and expert opinions on dog nutrition. Don't miss this chance to get informed and make the best choices for your furry friend.

RAW DOG FOOD AND COMPANY where Your Pet’s Health Is Our Business and Friends Don’t Let Friends Feed Kibble